AU2001286768A1 - Novel macrocycles and uses thereof - Google Patents

Novel macrocycles and uses thereof

Info

Publication number
AU2001286768A1
AU2001286768A1 AU2001286768A AU8676801A AU2001286768A1 AU 2001286768 A1 AU2001286768 A1 AU 2001286768A1 AU 2001286768 A AU2001286768 A AU 2001286768A AU 8676801 A AU8676801 A AU 8676801A AU 2001286768 A1 AU2001286768 A1 AU 2001286768A1
Authority
AU
Australia
Prior art keywords
sub
novel macrocycles
compounds
macrocycles
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286768A
Inventor
Daniel K. Baeschlin
Samuel J. Danishefsky
Robert M. Garbaccio
Neal Rosen
David Solit
Shawn J. Stachel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU2001286768A1 publication Critical patent/AU2001286768A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Abstract

The present invention relates to compounds having the structure (and pharmaceutically acceptable derivatives thereof) wherein R<SUB>0</SUB>-R<SUB>4</SUB>, Z, X, A-B, D-E, G-J, and K-L are as defined herein, the synthesis thereof and the use of these compounds as therapeutic agents.
AU2001286768A 2000-08-25 2001-08-24 Novel macrocycles and uses thereof Abandoned AU2001286768A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22827700P 2000-08-25 2000-08-25
US60/228,277 2000-08-25
US30455301P 2001-07-11 2001-07-11
US60/304,553 2001-07-11
US09/938,754 2001-08-24
PCT/US2001/026577 WO2002016369A2 (en) 2000-08-25 2001-08-24 Novel macrocycles and uses thereof
US09/938,754 US7115651B2 (en) 2000-08-25 2001-08-24 Macrocycles and uses thereof

Publications (1)

Publication Number Publication Date
AU2001286768A1 true AU2001286768A1 (en) 2002-03-04

Family

ID=27397829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286768A Abandoned AU2001286768A1 (en) 2000-08-25 2001-08-24 Novel macrocycles and uses thereof

Country Status (6)

Country Link
US (1) US7115651B2 (en)
EP (1) EP1315732B1 (en)
AT (1) ATE328888T1 (en)
AU (1) AU2001286768A1 (en)
DE (1) DE60120427D1 (en)
WO (1) WO2002016369A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
CA2482940A1 (en) * 2002-04-17 2003-10-23 Taisho Pharmaceuticals Co., Ltd. Hair growth tonic
WO2004111077A1 (en) 2003-06-18 2004-12-23 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor
EP1642880B1 (en) 2003-06-27 2013-09-04 Kyowa Hakko Kirin Co., Ltd. Hsp90 family protein inhibitors
EP1666064A4 (en) * 2003-08-22 2008-12-17 Kyowa Hakko Kogyo Kk Remedy for diseases associated with immunoglobulin gene translocation
US8329683B2 (en) 2006-06-02 2012-12-11 Nexgenix Pharmaceuticals, Llc Treatment of neurofibromatosis with radicicol and its derivatives
WO2008150302A1 (en) * 2007-06-04 2008-12-11 Nexgenix Pharmaceuticals Treatment of neurofibromatosis with radicicol and its derivatives
US8067412B2 (en) * 2006-08-11 2011-11-29 Universite De Strasbourg Macrocyclic compounds useful as inhibitors of kinases and HSP90
AU2008287542C1 (en) 2007-06-01 2015-01-22 The Trustees Of Princeton University Treatment of viral infections by modulation of host cell metabolic pathways
US8513440B2 (en) 2007-06-05 2013-08-20 Universite De Strasbourg Compositions and methods comprising analogues of radicicol A
CN101854955B (en) * 2007-09-10 2012-07-18 马萨诸塞大学 Mitochondria-targeted anti-tumor agents
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
EP2242359B1 (en) * 2008-01-15 2016-06-01 Universite De Strasbourg Synthesis of resorcylic acid lactones useful as therapeutic agents
US20090258869A1 (en) * 2008-02-08 2009-10-15 The Regents Of The University Of California Methods and compounds for treatment or prevention of substance-related disorders
CN102015673B (en) 2008-02-21 2014-10-29 昂科协同公司 Macrocyclic prodrug compounds useful as therapeutics
US8663210B2 (en) 2009-05-13 2014-03-04 Novian Health, Inc. Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
WO2016196256A2 (en) 2015-06-04 2016-12-08 University Of North Carolina At Greensboro Non-aromatic difluoro analogues of resorcylic acid lactones
US20230390416A1 (en) * 2020-10-16 2023-12-07 The Brigham And Women's Hospital, Inc. Compositions for inducing tumor immunity and reducing drug tolerance

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR96016E (en) 1966-06-29 1972-05-19 Commercial Solvents Corp Compound which can be used as a food supplement for animals.
FR96046E (en) * 1966-06-29 1972-05-19 Commercial Solvents Corp Compound which can be used as a food supplement for animals.
US3621036A (en) * 1969-02-27 1971-11-16 Merck & Co Inc Derivatives of zearalane
BE757082A (en) * 1970-02-16 1971-03-16 Commercial Solvents Corp PROCESS FOR PREPARING NEW PRODUCTS WITH ANTIBACTERIAL ACTIVITY
BE757083A (en) * 1970-02-16 1971-03-16 Commercial Solvents Corp NEW PRODUCTS WITH ANTIBACTERIAL ACTIVITY
US3901921A (en) * 1972-04-25 1975-08-26 Commercial Solvents Corp Synthesis of zearalanes and related compounds and intermediates useful in the syntheses thereof
US4035504A (en) * 1975-05-12 1977-07-12 Imc Chemical Group, Inc. Method for treating cholesterolemia by administering resorcylic acid lactone derivatives
US4088658A (en) * 1976-11-04 1978-05-09 Imc Chemical Group, Inc. Synthesis of dideoxyzearalane and related compounds
US4166764A (en) * 1978-02-01 1979-09-04 W. R. Grace & Co. Production of monorden
US4228079A (en) 1978-10-30 1980-10-14 W. R. Grace & Co. Dialkoxy monorden derivatives
US5650430A (en) * 1990-06-06 1997-07-22 Sankyo Company, Limited Radicicol derivatives, their preparation and their anti-tumor activity
KR920000763A (en) 1990-06-06 1992-01-29 가와무라 요시부미 Radicicol derivatives, preparation method thereof and antitumor activity thereof
GB9225396D0 (en) 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds
US5731343A (en) 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
DE69609325T2 (en) * 1995-04-26 2000-11-23 Kyowa Hakko Kogyo Kk DERIVATIVES OF RADICICOLS
JPH09202781A (en) * 1996-01-25 1997-08-05 Sankyo Co Ltd Radicicol derivative
ATE266017T1 (en) 1996-10-25 2004-05-15 Kyowa Hakko Kogyo Kk RADICICOL DERIVATIVES
WO1999055689A1 (en) 1998-04-24 1999-11-04 Kyowa Hakko Kogyo Co., Ltd. Radicicol derivatives
AU779438B2 (en) * 1998-12-24 2005-01-27 Novation Pharmaceuticals Inc. Compounds which affect mRNA stability and uses therefor
CA2370007A1 (en) 1999-04-09 2000-10-19 Sloan-Kettering Institute For Cancer Research Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
DK1250155T3 (en) 1999-12-22 2008-08-25 Scripps Research Inst Modulators and inhibitors of angiogenesis and vascular permeability

Also Published As

Publication number Publication date
US20020091151A1 (en) 2002-07-11
US7115651B2 (en) 2006-10-03
WO2002016369A3 (en) 2002-08-29
ATE328888T1 (en) 2006-06-15
EP1315732B1 (en) 2006-06-07
DE60120427D1 (en) 2006-07-20
EP1315732A2 (en) 2003-06-04
WO2002016369A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001286768A1 (en) Novel macrocycles and uses thereof
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
DE69831868D1 (en) Antithrombosemittel
AUPR213700A0 (en) Antiviral agents
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
BG106586A (en) Pyrazolopyramidines as therapeutic agents
IL133623A0 (en) Antithrombotic agents
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
AU2002213421A1 (en) Condensed pyridoindole derivatives
MXPA03010761A (en) Pharmaceutical combinations.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
MXPA03005601A (en) Novel compounds and compositions as cathepsin inhibitors.
DE50113345D1 (en) ARGININ MIMETICS AS FACTOR XA INHIBITORS
AU2001269063A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
MXPA04006041A (en) Pyridoquinoxaline antivirals.
MY138826A (en) 2,7-substituted indoles
MXPA03010766A (en) Novel compounds and compositions as cathepsin inhibitors.
YU30603A (en) Bridged piperazine derivatives
AU2001282871A1 (en) Antithrombotic agents
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
AU2002211493A1 (en) Indole derivatives as pde5-inhibitors